在一项回顾性多中心研究中诊断出神圣瘤的患者的长期结果
Aneta Maria Borkowska1,2, Andrzej Pieńkowski1, Paulina Chmiel1
1Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Cancer control : journal of the Moffitt Cancer Center
|March 11, 2025
概括
彻底的手术是神圣瘤的最佳治疗方法,提供更好的生存结果. 放射治疗为无法接受手术的患者提供了良好的长期效果,尽管复发仍然具有挑战性.
科学领域:
- 在瘤学瘤学.
- 整形外科 整形外科 整形外科
- 辐射瘤学 辐射瘤学
背景情况:
- 胆瘤是一种罕见的,激进的原发性骨肉瘤.
- 阻断切除是标准的治疗方法,但并不总是可行的.
- 放射治疗 (RTH) 是一种替代方案,但直接比较是有限的.
研究的目的:
- 为了比较手术和放射治疗 (RTH) 对圣骨性心瘤的有效性.
- 分析神经瘤患者的生存结果和复发治疗.
主要方法:
- 追溯分析了48名神圣冠状瘤患者 (2001-2020年).
- 治疗组:手术,终极放射治疗 (RTH) 或联合疗法.
- 卡普兰-梅尔方法用于无病生存率 (DFS) 和整体生存率 (OS) 分析.
主要成果:
- 激进手术在整体存活 (OS) 与RTH (P=0.01) 之间显示出显著的优势.
- 在激进手术组中 (平均68个月) 没有达到中位 OS,而RTH 则为62.3个月.
- 在手术和RTH之间,DFS或复发治疗结果没有显著差异.
结论:
- 彻底的手术是神圣瘤的首选治疗方法.
- 对于无法切除的病例,RTH提供了优秀的长期结果.
- 复发治疗仍然是一个挑战,需要进一步研究先进的技术.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...